163 related articles for article (PubMed ID: 32370741)
1. A meta-analytic evaluation of the correlation between event-free survival and overall survival in randomized controlled trials of newly diagnosed Ewing sarcoma.
Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
BMC Cancer; 2020 May; 20(1):379. PubMed ID: 32370741
[TBL] [Abstract][Full Text] [Related]
2. Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation.
Tanaka K; Kawano M; Iwasaki T; Matsuda S; Itonaga I; Tsumura H
Sci Rep; 2020 May; 10(1):8573. PubMed ID: 32444660
[TBL] [Abstract][Full Text] [Related]
3. Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation.
Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
BMC Cancer; 2019 Jan; 19(1):56. PubMed ID: 30634944
[TBL] [Abstract][Full Text] [Related]
4. Surrogacy analysis of intermediate end-points for overall survival in randomized controlled trials of rhabdomyosarcoma.
Kubota Y; Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
Sci Rep; 2022 Nov; 12(1):19381. PubMed ID: 36371419
[TBL] [Abstract][Full Text] [Related]
5. Efficacy Comparison of Six Chemotherapeutic Combinations for Osteosarcoma and Ewing's Sarcoma Treatment: A Network Meta-Analysis.
Zhang T; Zhang S; Yang F; Wang L; Zhu S; Qiu B; Li S; Deng Z
J Cell Biochem; 2018 Jan; 119(1):250-259. PubMed ID: 28266080
[TBL] [Abstract][Full Text] [Related]
6. GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
Mora J; Castañeda A; Perez-Jaume S; Lopez-Pousa A; Maradiegue E; Valverde C; Martin-Broto J; Garcia Del Muro X; Cruz O; Cruz J; Martinez-Trufero J; Maurel J; Vaz MA; de Alava E; de Torres C
Br J Cancer; 2017 Sep; 117(6):767-774. PubMed ID: 28787430
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma.
Liu H; Wang Y; Qi C; Xie T; Peng Z; Li J; Shen L; Zhang X
Front Oncol; 2022; 12():835389. PubMed ID: 35463354
[TBL] [Abstract][Full Text] [Related]
8. The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma.
Rasper M; Jabar S; Ranft A; Jürgens H; Amler S; Dirksen U
Pediatr Blood Cancer; 2014 Aug; 61(8):1382-6. PubMed ID: 24729428
[TBL] [Abstract][Full Text] [Related]
9. Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation.
Xie W; Regan MM; Buyse M; Halabi S; Kantoff PW; Sartor O; Soule H; Berry D; Clarke N; Collette L; D'Amico A; Lourenco RA; Dignam J; Eisenberger M; James N; Fizazi K; Gillessen S; Loriot Y; Mottet N; Parulekar W; Sandler H; Spratt DE; Sydes MR; Tombal B; Williams S; Sweeney CJ;
J Clin Oncol; 2020 Sep; 38(26):3032-3041. PubMed ID: 32552276
[TBL] [Abstract][Full Text] [Related]
10. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
[TBL] [Abstract][Full Text] [Related]
11. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
[TBL] [Abstract][Full Text] [Related]
12. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and survival in Ewing's sarcoma treated by limb salvage surgery.
Alvarez-SanNicolas J; Gracia-Alegria I; Trullols-Tarrago L; Peiro-Ibañez A; Lamas-Gomez C
Clin Transl Oncol; 2019 Oct; 21(10):1374-1382. PubMed ID: 30798513
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group.
Cash T; McIlvaine E; Krailo MD; Lessnick SL; Lawlor ER; Laack N; Sorger J; Marina N; Grier HE; Granowetter L; Womer RB; DuBois SG
Pediatr Blood Cancer; 2016 Oct; 63(10):1771-9. PubMed ID: 27297500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Latino and non-Latino patients with Ewing sarcoma.
Sharib J; Horvai A; Gray Hazard FK; Daldrup-Link H; Goldsby R; Marina N; DuBois SG
Pediatr Blood Cancer; 2014 Feb; 61(2):233-7. PubMed ID: 23970433
[TBL] [Abstract][Full Text] [Related]
16. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
[TBL] [Abstract][Full Text] [Related]
17. Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94.
Ash S; Yaniv I; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Avigad S; Cohen IJ
J Pediatr Hematol Oncol; 2019 Mar; 41(2):105-111. PubMed ID: 30570510
[TBL] [Abstract][Full Text] [Related]
18. Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients.
Tao HT; Hu Y; Wang JL; Cheng Y; Zhang X; Wang H; Zhang SJ
Asian Pac J Cancer Prev; 2013; 14(5):2967-71. PubMed ID: 23803063
[TBL] [Abstract][Full Text] [Related]
19. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
[TBL] [Abstract][Full Text] [Related]
20. Event-Free Survival as a Surrogate for Overall Survival in Gastric and Gastroesophageal Junction Adenocarcinoma: A Meta-analysis in the Neoadjuvant ± Adjuvant Setting.
Wainberg ZA; Xie J; Valderrama A; Yin L; Zhang S; Shih CS; Bhagia P; Gu Q; Shitara K; Janjigian YY; Tabernero J
Clin Cancer Res; 2023 Apr; 29(7):1360-1367. PubMed ID: 36652563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
